Salubris(SZ:002294) Xin Lang Cai Jing·2025-10-15 12:50Core Viewpoint - The announcement regarding the partial pledge release of shares by the controlling shareholder of Xinlitai has attracted market attention, indicating a positive signal for investor confidence in the company [1]. Summary by Relevant Sections Release of Pledge - Xinlitai Pharmaceutical Co., Ltd. (Hong Kong Xinlitai) has released a total of 1,700,000 shares from pledge, which accounts for 2.68% of its holdings and 1.52% of the company's total share capital [2]. - The released shares include 1,100,000 shares (1.73% of its holdings) and 600,000 shares (0.94% of its holdings), with the pledges initiated on June 13, 2018, and October 11, 2019, respectively, and set to be released by October 14, 2025 [2]. Pledged Shares Situation - As of the announcement date, Xinlitai Pharmaceutical holds 63,527,938 shares, representing 56.99% of the company, with 9,700,000 shares currently under pledge, which is 15.27% of its total holdings and 8.70% of the company's total share capital [3]. - There are no frozen, marked, auctioned, or trust-set shares, nor any non-operational fund occupation or illegal guarantees that could harm the interests of the listed company [3]. Financial Health and Control - Xinlitai Pharmaceutical has a good credit status and repayment capability, indicating that the risks associated with pledged shares are manageable [3]. - The pledge of shares will not lead to any change in the actual control of the company and will not affect its production, operation, or governance [3].